About Scopio Labs
Scopio Labs is a healthcare AI company that develops full-field digital cell morphology platforms, including the Scopio X100 and X100HT, along with integrated software applications. These platforms are designed to digitize, analyze, and automate the review of blood smears and bone marrow aspirates for clinical laboratories and hospitals. The core of their technology lies in computational photography, which enables the capture of high-resolution (100X) images across the entire field of view of a sample, effectively overcoming the traditional trade-off between resolution and field of view in microscopy.
For physicians and laboratory teams, Scopio Labs’ solutions offer a comprehensive digital picture of blood samples, enhancing diagnostic accuracy and efficiency. The platforms incorporate AI for advanced analysis and decision support, streamlining workflows and facilitating remote consultation and collaboration through secure hospital networks. This capability is particularly beneficial for telehematology, allowing specialists to review and analyze samples from anywhere.
The company’s offerings aim to revolutionize first-line diagnostic testing by expediting access to life-saving treatments and improving patient outcomes through earlier and more accurate detection and diagnosis of various blood-related medical conditions, such as cancers, anemias, and bleeding disorders. Scopio Labs has received FDA clearance and CE marking for its peripheral blood smear and bone marrow aspirate applications, signifying their clinical relevance and readiness for market adoption.
Focus Areas
Business Intelligence
| Key Investors | OurCrowd, Aurum Ventures, Fortissimo Capital, Viola Growth, Ilex Medical, Mizrahi Tefahot Invest, Kreos Capital, B Capital Group, Olive Tree Ventures, Danaher Ventures, Insight Capital Partners |
| Partnerships | Beckman Coulter, Siemens Healthineers |
| Technology | Proprietary Full-Field Digital Cell Morphology platforms, computational photography, AI-powered Decision Support System (DSS), cloud-native for remote review, integration with Laboratory Information Systems (LIS) |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
For physicians, Scopio Labs' technology offers several significant advantages:nn* **Enhanced Diagnostic Confidence:** The Full-Field imaging at 100x magnification provides a complete and detailed view of the entire smear, eliminating the need to revert to a manual microscope and ensuring no diagnostically relevant areas are missed. The AI-powered decision support system offers consistent, standardized analysis, leading to more reliable and accurate diagnoses.n* **Faster Turnaround Times & Efficiency:** Automated workflows and AI analysis significantly reduce the time required for PBS and BMA reviews (e.g., up to 60% reduction in TAT for PBS), allowing for quicker diagnoses and initiation of treatment.n* **Improved Access to Expertise & Collaboration:** Remote review capabilities enable seamless consultation and collaboration with specialists, regardless of their physical location, facilitating second opinions and balancing workloads across different sites.n* **Standardization and Reduced Variability:** The AI-guided system helps standardize cell counting and analysis, reducing inter-operator variability and ensuring consistent quality across the laboratory.n* **Early Detection Potential:** By analyzing significantly more cells than manual methods, the technology improves the statistical significance of findings and the potential for earlier detection of rare cell types and diseases.
Scopio Labs' systems are designed for integration within existing laboratory ecosystems. Their browser-based application can be accessed within a secure medical facility network. They also offer connectivity with other lab automation systems, such as Beckman Coulter's hematology workcells, to create a fully integrated workflow from complete blood count (CBC) to slide staining and peripheral blood smear review.
What the Web Says
Scopio Labs receives generally positive feedback for its innovative digital microscopy technology, particularly its full-field imaging and AI capabilities, which are seen as significant advancements in hematology and pathology. Employer reviews indicate a dynamic, fast-paced work environment with opportunities for growth, though some employees note challenges related to workload and communication in a rapidly expanding company.
Overall: PositiveStrengths
- Innovative full-field imaging and AI for hematology/pathology
- Improved workflow efficiency and diagnostic accuracy
- High-resolution imaging and advanced analytics
- Positive impact on patient care through faster diagnostics
- Dynamic and challenging work environment with growth opportunities
- Strong focus on cutting-edge technology and R&D
Limitations
- Steep learning curve for new users
- Potential for high workload and fast-paced environment
- Some reports of communication challenges in a rapidly growing company
- Integration with existing lab systems can be complex
- Cost of implementation may be a barrier for some labs
- Limited public reviews on specific platforms like Capterra
Based on reviews from: G2, Glassdoor, Healthcare IT News, Reddit, Various industry publications and forums
Last updated: 2026-07-19
Videos
News, demos, and interviews about Scopio Labs.
Videos load interactively. If none appear, search YouTube for Scopio Labs →
Press & Coverage
Investors
Who's funded Scopio Labs.
Related Companies
Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]
TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]
TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]
Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]
Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]
SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]